Literature DB >> 19913279

Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.

Wataru Tokuyama1, Tetuo Mikami, Mikio Masuzawa, Isao Okayasu.   

Abstract

Angiosarcoma of the skin is an extremely rare malignant tumor of vascular origin that usually arises in the scalp and face of elderly persons. To clarify its characteristic features and cell cycle kinetics, we quantitatively evaluated the expression of cell cycle-related molecules and vascular endothelial growth factors using immunohistochemical staining, for comparison with 2 benign vascular tumors of the skin, the capillary hemangioma and the cavernous hemangioma. Cell proliferation, determined with reference to the Ki-67 labeling index, was highest in angiosarcomas and lowest in cavernous hemangiomas (angiosarcomas versus capillary hemangioma, P = .014; capillary hemangioma versus cavernous hemangiomas, P = 1.4 x 10(-4)). Similar differences were also found in cyclin A, cyclin E, and p21(Waf1) expression. Expressions of cyclin D1 and p16(INK4A) were also significantly higher in angiosarcoma than in cavernous hemangioma. Expressions of these 5 proteins showed significant positive correlations with Ki-67 labeling indices (Spearman rho = 0.91-0.43). Expression levels of vascular endothelial growth factor and its receptor, VEGFR-2, were highest in angiosarcomas. VEGF-C expression in angiosarcomas was significantly higher than in cavernous hemangiomas, and its receptor VEGFR-3 expression was highest in angiosarcomas. Furthermore, significant positive correlations of these protein expression with Ki-67 labeling indices were noted (Spearman rho = 0.88-0.40). Among them, VEGFR-3 showed the highest correlation coefficient. These results suggest that not only VEGFR-2-mediated signal but also VEGFR-3-mediated signal may contribute to proliferation of vascular tumor cells as autocrine and paracrine signaling factors. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913279     DOI: 10.1016/j.humpath.2009.08.021

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

Review 1.  Targeted therapy in sarcomas other than GIST tumors.

Authors:  Douglas Sborov; James L Chen
Journal:  J Surg Oncol       Date:  2014-10-20       Impact factor: 3.454

Review 2.  Angiosarcoma of the thyroid: a case report with review of the literature.

Authors:  Arshpreet Kaur; Mukund S Didolkar; Asha Thomas
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

3.  Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature.

Authors:  Ping Yang; Qi Zhu; Fuqiang Jiang
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

Review 4.  Dynamic Interactions between Tumor Cells and Brain Microvascular Endothelial Cells in Glioblastoma.

Authors:  Erika Testa; Claudia Palazzo; Roberta Mastrantonio; Maria Teresa Viscomi
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

5.  Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.

Authors:  Nicolas Penel; Isabelle Ray-Coquard; Christine Bal-Mahieu; Christine Chevreau; Axel Le Cesne; Antoine Italiano; Emmanuelle Bompas; Stéphanie Clisant; Brigitte Baldeyrou; Amélie Lansiaux; Yves-Marie Robin; Jacques-Olivier Bay; Sophie Piperno-Neumann; Jean-Yves Blay; Charles Fournier
Journal:  Target Oncol       Date:  2013-11-12       Impact factor: 4.493

6.  Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice.

Authors:  Morvarid Farhang Ghahremani; Enrico Radaelli; Katharina Haigh; Sonia Bartunkova; Lieven Haenebalcke; Jean-Christophe Marine; Steven Goossens; Jody J Haigh
Journal:  Cell Cycle       Date:  2014-03-11       Impact factor: 4.534

7.  Thyroid Angiosarcoma-Rare Case or Hard to Find.

Authors:  Konstantinos Sapalidis; Nikos Kefes; Konstantinos Romanidis; Paul Zarogoulidis; Stelian Pantea; Otilia Constantina Rogoveanu; Ion Rogoveanu; Anastasios Vagionas; Katerina Zarampouka; Kosmas Tsakiridis; Isaac Kesisoglou
Journal:  Curr Health Sci J       Date:  2020-12-31

8.  Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.

Authors:  Petra Hamerlik; Justin D Lathia; Rikke Rasmussen; Qiulian Wu; Jirina Bartkova; MyungHee Lee; Pavel Moudry; Jiri Bartek; Walter Fischer; Jiri Lukas; Jeremy N Rich; Jiri Bartek
Journal:  J Exp Med       Date:  2012-03-05       Impact factor: 14.307

9.  Angiogenesis gene expression in murine endothelial cells during post-pneumonectomy lung growth.

Authors:  Miao Lin; Kenji Chamoto; Barry C Gibney; Grace S Lee; Dinee Collings-Simpson; Jan Houdek; Moritz A Konerding; Akira Tsuda; Steven J Mentzer
Journal:  Respir Res       Date:  2011-07-27

Review 10.  Molecular mechanisms underpinning sarcomas and implications for current and future therapy.

Authors:  Victoria Damerell; Michael S Pepper; Sharon Prince
Journal:  Signal Transduct Target Ther       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.